AC Immune (ACIU) Other Non Operating Income (2016 - 2026)
AC Immune's (ACIU) quarterly Other Non Operating Income came in at -$224752.8 in Q1 2026, up 30.8% year-on-year from -$171832.2 in Q1 2025, and up 38.06% on a QoQ basis from -$362839.2 in Q4 2025.
AC Immune (ACIU) Other Non Operating Income (2016 - 2026) Analysis & Trends
AC Immune (ACIU) has 11 years of Other Non Operating Income data on file, last reported at -$224752.8 in Q1 2026.
- On a quarterly basis, Other Non Operating Income rose 30.8% year-over-year to -$224752.8 in Q1 2026; TTM through Mar 2026 was -$3.3 million, a 16.87% increase from a year earlier, with the FY2025 full-year figure at -$3.4 million, down 85.33% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$224752.8, up from -$362839.2 in the prior quarter.
- Over the last five years, Other Non Operating Income for ACIU reached as high as $2.2 million in Q4 2024 and fell as low as -$3.1 million in Q3 2024.
- Historically, Other Non Operating Income has averaged -$354599.2 across 5 years, with a median of -$55139.3 in 2023.
- On a YoY basis, Other Non Operating Income climbed as much as 3451.49% in 2024 and fell as far as 15460.19% in 2024.
- Year by year, Other Non Operating Income stood at -$113144.4 in 2022, then slumped by 861.51% to -$1.1 million in 2023, then soared by 306.19% to $2.2 million in 2024, then sank by 116.18% to -$362839.2 in 2025, then soared by 38.06% to -$224752.8 in 2026.
- Per Business Quant data, the three most recent Other Non Operating Income figures were -$224752.8 in Q1 2026, -$362839.2 in Q4 2025, and -$15001.3 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | AC Immune | 222.66 Mn | 222.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -224,752.82 |
| Dec 31, 2025 | -362,839.24 |
| Sep 30, 2025 | -15,001.31 |
| Jun 30, 2025 | -2.67 Mn |
| Mar 31, 2025 | -324,777.16 |
| Dec 31, 2024 | 2.24 Mn |
| Sep 30, 2024 | -3.08 Mn |
| Jun 30, 2024 | -2.77 Mn |
| Mar 31, 2024 | 1.85 Mn |
| Dec 31, 2023 | -1.09 Mn |
| Sep 30, 2023 | 75,854.22 |
| Jun 30, 2023 | -17,794.81 |
| Mar 31, 2023 | -55,139.29 |
| Dec 31, 2022 | -113,144.39 |
| Sep 30, 2022 | 17,602.76 |
| Jun 30, 2022 | 358,211.09 |
| Mar 31, 2022 | 151,593.17 |
| Dec 31, 2021 | -405,603.78 |
| Sep 30, 2021 | 132,873.75 |
| Jun 30, 2021 | -195,203.19 |